US equities |
SPCX $167.41 ▲+5.32% NVDA $236.33 ▲+1.02% MU $1,064.90 ▼-0.93% TSLA $378.31 ▲+2.08% MSFT $525.89 ▲+1.62% SNDK $1,708.26 ▼-0.68% INTC $117.39 ▼-1.63% META $744.38 ▲+2.24%
FinancialContent

Articles published by BiomX Inc.

News headline image
BiomX To Present at H.C. Wainwright 24th Annual Global Investment Conference
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Reports Second Quarter 2022 Financial Results and Provides Business Update
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX to Host Second Quarter 2022 Financial Results Conference Call and Webcast on August 10, 2022
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Announces Voluntary Delisting from the Tel Aviv Stock Exchange
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
Boehringer Ingelheim and BiomX Collaborate to Discover Inflammatory Bowel Disease Microbiome Biomarkers
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Announces Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Announces Corporate Restructuring
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Announces Publication in the Journal, Bioinformatics
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Reports First Quarter 2022 Financial Results and Provides Business Update
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX to Host Key Opinion Leader Event on BX004 for Treatment of Pseudomonas Aeruginosa Infections in Cystic Fibrosis Patients
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX to Host First Quarter 2022 Financial Results Conference Call and Webcast on May 11, 2022
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast on March 30, 2022
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Presenting at Three Upcoming Investor Conferences
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Announces Therapeutics Development Award of up to $5 Million from the Cystic Fibrosis Foundation
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX to Present Preclinical Results with BX004 in Cystic Fibrosis at the 44th European Cystic Fibrosis Conference
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 24, 2021
From BiomX Inc.
Via Business Wire
Tickers PHGE
News headline image
BiomX to Present at Upcoming April Investor Events
From BiomX Inc.
Via Business Wire
Tickers PHGE